Replies to post #331317 on Avid Bioservices Inc (CDMO)

[jakedogman1]

Avid is a tough one to figure out and given the consolidation in the cdmo space and demand for biologics manuf, my guess is a DCF model will be used whereby the future expansion less construction cost and fda/eu approval costs will be factored in.